2011
DOI: 10.1074/jbc.m111.235606
|View full text |Cite
|
Sign up to set email alerts
|

Plasmin Overcomes Resistance to Prostaglandin E2 in Fibrotic Lung Fibroblasts by Reorganizing Protein Kinase A Signaling

Abstract: Collagen deposition by fibroblasts contributes to scarring in fibrotic diseases. Activation of protein kinase A (PKA) by cAMP represents a pivotal brake on fibroblast activation, and the lipid mediator prostaglandin E 2 (PGE 2 ) exerts its well known antifibrotic actions through cAMP signaling. However, fibrotic fibroblasts from the lungs of patients with idiopathic pulmonary fibrosis, or of mice with bleomycin-induced fibrosis, are resistant to the normal collagen-inhibiting action of PGE 2 . In this study, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(32 citation statements)
references
References 46 publications
1
31
0
Order By: Relevance
“…Although TGF-␤1-induced SRF up-regulation was also attenuated by PGE2 in IPF cells, the extent of inhibition was more modest than in nonfibrotic cells. This too is characteristic of our prior observations in fibrotic fibroblasts from both humans and mice, in which we have found decreased sensitivity to the inhibitory actions of PGE 2 on processes such as proliferation and collagen I expression (21), which reflects both epigenetic down-regulation of EP2 expression (40) as well as impaired PKA activation (22).…”
Section: Discussionmentioning
confidence: 52%
See 2 more Smart Citations
“…Although TGF-␤1-induced SRF up-regulation was also attenuated by PGE2 in IPF cells, the extent of inhibition was more modest than in nonfibrotic cells. This too is characteristic of our prior observations in fibrotic fibroblasts from both humans and mice, in which we have found decreased sensitivity to the inhibitory actions of PGE 2 on processes such as proliferation and collagen I expression (21), which reflects both epigenetic down-regulation of EP2 expression (40) as well as impaired PKA activation (22).…”
Section: Discussionmentioning
confidence: 52%
“…PKA RI and PKA RII agonists and forskolin were purchased from Biolog (Hayward, CA). We used PKA RI and RII subunit-specific agonists each at 500 M based on our previous dose-response studies (22). Unless otherwise specified, TGF-␤1 was used at a final concentration of 2 ng/ml, and cells were pretreated for 30 min with or without PGE 2 at a final concentration of 500 nM before addition of TGF-␤1.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The PDE4 inhibitor rolipram also reduced epithelial-mesenchymal transition (Kolosionek et al, 2009). PGE 2 -induced cAMP elevation exerts antifibrotic properties in human and mouse lung fibroblasts, and defects in the synthesis of PGE 2 correlate with the degree of airway remodeling in mice (Bauman et al, 2010;Okunishi et al, 2011;Stumm et al, 2011). PGE 2 also inhibits collagen deposition in fibrotic lung fibroblasts through a PGE 2 -sensing AKAP450 (AKAP9)-PKA-protein phosphatase 2A multiprotein complex Fig.…”
Section: E Epac and The Lungmentioning
confidence: 99%
“…Now we know that EP2 promoter hypermethylation (45), or loss of protein kinase A expression, explains why IPF fibroblasts are nonresponsive to PGE 2 (44). Fortunately, stimulation of lung fibroblasts in the presence of plasmin can overcome the resistance to PGE 2 signaling by reorganizing protein kinase A signaling (46)…”
Section: Ccr2-binding Chemokines and Lung Fibrosis: More Than Just MImentioning
confidence: 99%